Results showed that there were no significant differences in age, HER2 status, KI67 level, and extent of the tumor (T1–T4) between the FBC and MBC groups (Supplementary Data 2), avoiding the influence of these factors on the comparison. The gene discussed is ERBB2; the disease is neoplasm.